Bioequivalence Study of 100-mg Cilostazol Tablets in Healthy Thai Adult Volunteers
Open Access
- 15 July 2019
- journal article
- research article
- Published by Elsevier in Current Therapeutic Research
- Vol. 91, 11-16
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Population Pharmacokinetic Analysis of Diurnal and Seasonal Variations of Plasma Concentrations of Cilostazol in Healthy VolunteersTherapeutic Drug Monitoring, 2014
- Pharmacokinetic Comparison of Sustained- and Immediate-Release Oral Formulations of Cilostazol in Healthy Korean Subjects: A Randomized, Open-Label, 3-Part, Sequential, 2-Period, Crossover, Single-Dose, Food-Effect, and Multiple-Dose StudyClinical Therapeutics, 2011
- Variability and Impact on Design of Bioequivalence StudiesBasic & Clinical Pharmacology & Toxicology, 2010
- Cilostazol for peripheral arterial disease2008
- Randomized Comparison of Cilostazol vs Clopidogrel After Drug-Eluting Stenting in Diabetic Patients CIilostazol for Diabetic Patients in Drug-Eluting Stent (CIDES) TrialCirculation Journal, 2008
- Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)European Journal of Vascular and Endovascular Surgery, 2007
- CilostazolAmerican Journal of Cardiovascular Drugs, 2003
- Cilostazol (Pletal®): A Dual Inhibitor of Cyclic Nucleotide Phosphodiesterase Type 3 and Adenosine UptakeCardiovascular Drug Reviews, 2001
- Usefulness of nisoldipine for prevention of restenosis after percutaneous transluminal coronary angioplasty (results of the NICOLE study)The American Journal of Cardiology, 2001
- CilostazolDrugs & Aging, 1999